GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

International said Friday that CEO Sima Sistani is stepping down immediately. She will be replaced by Tara Comonte, a board ...

WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

Shares of Novo Nordisk (NVO) slipped on Friday following a note from JPMorgan's Richard Vosser. Vosser warned that the ...

The Senate investigation showed Americans pay $1,349 a month for the weight-loss drug Wegovy, which is priced at $92 in the United Kingdom.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

In this week’s Bloom Boost – health news you might have missed, Gayle Guyardo the host of the nationally syndicated health and wellness show Bloom  shares U.S. senators are ...

Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.

Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.

The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and ...